Edit |   |
---|---|
Antigenic Specificity | IL1B, Human (Canakinumab biosimilar) |
Clone | Canakinumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, IHC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL1B Recombinant Antibody (Canakinumab). Canakinumab (INN), sold under the brand name Ilaris is a medication for the treatment of systemic juvenile idiopathic arthritis (SJIA) and active Still's disease, including adult-onset Still's disease (AOSD). It is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha. |
Immunogen | n/a |
Other Names | Anti-IL1B Recombinant Antibody, Research Grade Canakinumab, Anti-Human IL1B Recombinant Antibody(Canakinumab), ACZ885, Antibody Drug Analogues, Monoclonal Antibody, YR1159, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 914613-48-2 |
Catalog # | YR1159 |
Price | please inquire |
Order / More Info | IL1B, Human (Canakinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |